Navigation Links
Vanda Pharmaceuticals to Announce Third Quarter 2007 Financial Results on November 8, 2007
Date:10/30/2007

Conference Call and Webcast to Follow

ROCKVILLE, Md., Oct. 30 /PRNewswire-FirstCall/ -- Vanda Pharmaceuticals Inc. (Nasdaq: VNDA), a biopharmaceutical company focused on the development and commercialization of clinical-stage product candidates for central nervous system disorders, today announced it will release results for the quarter ended September 30, 2007, on Thursday, November 8, 2007, before the market opens. A full text copy of the release will be disseminated at that time.

Mihael H. Polymeropoulos, M.D., President and Chief Executive Officer, will host a conference call to discuss the results and other corporate developments at 10:30 AM ET on Thursday, November 8, 2007. Also participating on the call will be Steven A. Shallcross, Senior Vice President and CFO. To participate in the conference call, dial the appropriate number below shortly before the 10:30 AM start time and ask for the Vanda Pharmaceuticals conference call hosted by Dr. Polymeropoulos.

The teleconference dial-in numbers are as follows:

Domestic callers 1-866-578-5801

International callers 1-617-213-8058

The conference call will be broadcast simultaneously and archived on the Company's Web site, http://www.vandapharma.com. Investors should go to the Web site at least 15 minutes early to register, download, and install any necessary audio software.

A replay of the call will be available on Thursday, November 8, 2007, beginning at 12:30 PM ET and will be accessible until Thursday, November 15, 2007, at 5:00 PM ET. The replay call-in number is 1-888-286-8010 for domestic callers and 1-617-801-6888 for international callers. The access
'/>"/>

SOURCE Vanda Pharmaceuticals Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Supply of Radiopharmaceuticals Hampered by Attacks
2. FDA approves Watson Pharmaceuticals Oxytrol patch
3. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
4. Antigenics Pharmaceuticals plans for Phase III trial of its Melanoma vaccine
5. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
6. Top Pharmaceuticals Influence Doctors Prescriptions
7. More Study On Side Effects of ADHD Drug Needed: Shire Pharmaceuticals
8. Personalized Medicine and Innovative Pharmaceuticals
9. New lease of life for asthmatics by Accentia Biopharmaceuticals
10. Pravastatin Launched by Watson Pharmaceuticals
11. Tata Industries picks up stake in Indigene Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...PRNewswire/ -- NursingCenter.com, the premier site... reviewed content, has been,updated to improve th...d,users. Powered by Lippincott Williams & Wil...00 peer-reviewed continuing education activities a...50 leading nursing journals.,Lippincott Williams ...
(Date:11/21/2008)...wswire/ -- The general membership of the Medical,... individuals at their Annual,Awards Dinner to be ...York. A,Lifetime Achievement Award will also be g... Advertising Hall of Fame are: , Ronald Pantell...t position,at Sudler & Hennessey. In 1980 he ...
(Date:11/21/2008)...rugs do not cause genetic damage that can lead to ...ews) -- Two popular medications for treating atten...cause genetic damage linked to an increased risk f...tudy, done by researchers at Duke University Medic...ounters a previous one that reported biomarkers as...
(Date:11/21/2008)...wire/ -- In a statewide survey, 33 physicians cred...rgery at Presbyterian Hospital of Dallas were hono...of " Super Doctors ." , , Each year, the pu...onal Media, Inc. to survey more than 38,000 medica..."If you needed medical care, which doctor would yo...
Breaking Medicine News(10 mins):Health News:NursingCenter.com Launches New Features to Improve User Experience 2Health News:NursingCenter.com Launches New Features to Improve User Experience 3Health News:Ronald Pantello, Harry Sweeney, and David Wood Voted Into Medical Advertising Hall of Fame. 2Health News:Ronald Pantello, Harry Sweeney, and David Wood Voted Into Medical Advertising Hall of Fame. 3Health News:ADHD Medications Don't Pose Cancer Risk 2Health News:Annual List of 'Super Doctors' Features 33 Texas Institute for Surgery Physicians 2
...ty for superstition and marketing to come together... are over-booked and Live Earth concerts as well a...s take place that day. "Number 7 has a magic sacr...ng luck," said numerologist Jean-Daniel Fermier. S...
...ina is expected to replace France as the world's t...ewed by a foreign news agency said China received ...ivals from Hong Kong, Macau, and Taiwan, compared ...978. They said that while tourism growth in Franc...
... moving out from her Sierra Towers apartment to le...apartment is at a very happening place, so the 'pa...ken car crash has decided not to go back there onc...rapy. "The Sierra Towers is party central," New Y...
...aginal lubricants control the growth of infection ... cervical cancer. The study was conducted by a t...ional Cancer Institute, Bethesda, Maryland. The p...experiments was that HPV survive only in humans, m...
Other Medicine News:Health News:A Lucky Number? 7/7/07 2Health News:A Lucky Number? 7/7/07 3Health News:China to Replace France as World's Top Tourism Destination by 2014 2Health News:Vaginal Lubricants can Reduce Cervical Cancer Risk 2
(Date:11/19/2008)...istical significance , , ISELIN, N.J., Nov.... (Nasdaq: PARS ) today announced results from it...ion (NE) drug delivery technology formulated with ...-center, randomized, double-blinded, placebo-contr...he Company,s 3% Diclofenac Diethanolamine NanoEmul...
(Date:11/18/2008)...all/ -- NeuroDiscovery Ltd (ASX:,NDL), a specialt...nt Company,and Sosei Group Corporation ("Sosei";...l biopharmaceutical company, today announce that N...linical efficacy data for NSL-043/SD118.,This inv...pathic pain and has,successfully completed Phase ...
(Date:11/18/2008)...gnosed, elderly AML patients , , PRINCETON,...cals today announced that the first patient has be...of CPX-351 (Cytarabine:Daunorubicin) Liposome Inje...id leukemia (AML). , , The first patient wa...al College of Cornell University and New York Pre...
(Date:11/12/2008)...Watson, Marilyn & James Simons and,Sherry Lansing ... 12 J. Craig Venter,Ph...Institute (JCVI), was,awarded the Double Helix Med...vember 6th at a gala event in New York City., Dr.... Dr. James D.,Watson for making each of their indi...
Breaking Medicine Technology:Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 3Celator(R) Pharmaceuticals Announces Enrollment of First Patient in Phase 2 Study with CPX-351 2Celator(R) Pharmaceuticals Announces Enrollment of First Patient in Phase 2 Study with CPX-351 3J. Craig Venter, Ph.D. Receives Double Helix Medal from Cold Spring Harbor Laboratory 2ASTRO selects pediatric oncologist as 2008 honorary member 25838 1ASTRO selects pediatric oncologist as 2008 honorary member 25838 2Combination Therapy Helps to Combat Myeloma 25834 1Combination Therapy Helps to Combat Myeloma 25834 2Combination Therapy Helps to Combat Myeloma 25834 3Trubion Pharmaceuticals to Present at Fall 2008 Morgan Stanley Global Healthcare Unplugged Conference in New York 7358 1Trubion Pharmaceuticals to Present at Fall 2008 Morgan Stanley Global Healthcare Unplugged Conference in New York 7358 2Iowa State University researcher shows proteins have controlled motions 4624 1Iowa State University researcher shows proteins have controlled motions 4624 2
...patients treated with VELCADE, cyclophosphamide,a...ne 28, 2007 /PRNewswire-FirstCall/ -- Millennium,P...ation of results,from clinical trials of VELCADE b... / complete response(1) (CR) rates in previously,t...ngs were,presented at the prestigious 11th Interna...
...Synagis Decreases Incidence of Recurrent Wheeze by...Md., June 29, 2007,/PRNewswire-FirstCall/ -- Abbot...tudy, published in the July issue of Journal of,Pe...palivizumab),may reduce recurrent wheezing in prem...study showed that premature infants without,chroni...
Other Medicine Technology:Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma 2Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma 3Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma 4Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma 5Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma 6New Study in Journal of Pediatrics Suggests Synagis (Palivizumab),May Reduce Subsequent Recurrent Wheezing in Preterm Infants 2New Study in Journal of Pediatrics Suggests Synagis (Palivizumab),May Reduce Subsequent Recurrent Wheezing in Preterm Infants 3New Study in Journal of Pediatrics Suggests Synagis (Palivizumab),May Reduce Subsequent Recurrent Wheezing in Preterm Infants 4New Study in Journal of Pediatrics Suggests Synagis (Palivizumab),May Reduce Subsequent Recurrent Wheezing in Preterm Infants 5
Healon vitreous aspirating cannula, 21 gauge.
Flexible silicone tip cannula allows atraumatic access through retinal tear or hole for aspiration of subretinal fluids. Silicone tube extends 6mm beyond end of cannula. Luer lock hub for easy, sec
Ultra thin wall .90 mm (20 g) cannula allows maximum flow rate, 6 mm in length. Cannula beveled for easy insertion through sclerotomy. 3201 has 16 cm (6 in) high pressure PVC tubing to allow injectio
...ective line of compact CO2 systems combines portab...ature an extremely accurate laser beam, as well as...cially advantageous for small operating theatres a.... Use of special contact tips and accessories allo...
Medicine Products: